129 related articles for article (PubMed ID: 17657603)
1. Serum sulfatides as a novel biomarker for cardiovascular disease in patients with end-stage renal failure.
Hu R; Li G; Kamijo Y; Aoyama T; Nakajima T; Inoue T; Node K; Kannagi R; Kyogashima M; Hara A
Glycoconj J; 2007 Dec; 24(9):565-71. PubMed ID: 17657603
[TBL] [Abstract][Full Text] [Related]
2. Serum sulfatide abnormality is associated with increased oxidative stress in hemodialysis patients.
Yuzhe H; Kamijo Y; Hashimoto K; Harada M; Kanno T; Sugiyama E; Kyogashima M; Oguchi T; Nakajima T; Kanno Y; Aoyama T
Hemodial Int; 2015 Jul; 19(3):429-38. PubMed ID: 25645724
[TBL] [Abstract][Full Text] [Related]
3. Kidney dysfunction induced by protein overload nephropathy reduces serum sulfatide levels in mice.
Li G; Hu R; Kamijo Y; Nakajima T; Aoyama T; Ehara T; Shigematsu H; Kannagi R; Kyogashima M; Hara A
Nephrology (Carlton); 2009 Oct; 14(7):658-62. PubMed ID: 19796024
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a quantitative, qualitative, and high-throughput analysis of sulfatides from small amounts of sera by matrix-assisted laser desorption ionization-time of flight mass spectrometry.
Li G; Hu R; Kamijo Y; Nakajima T; Aoyama T; Inoue T; Node K; Kannagi R; Kyogashima M; Hara A
Anal Biochem; 2007 Mar; 362(1):1-7. PubMed ID: 17254536
[TBL] [Abstract][Full Text] [Related]
5. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
[TBL] [Abstract][Full Text] [Related]
6. Acute kidney injury induced by protein-overload nephropathy down-regulates gene expression of hepatic cerebroside sulfotransferase in mice, resulting in reduction of liver and serum sulfatides.
Zhang X; Nakajima T; Kamijo Y; Li G; Hu R; Kannagi R; Kyogashima M; Aoyama T; Hara A
Biochem Biophys Res Commun; 2009 Dec; 390(4):1382-8. PubMed ID: 19895791
[TBL] [Abstract][Full Text] [Related]
7. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
8. Impact of chronic kidney dysfunction on serum Sulfatides and its metabolic pathway in mice.
Yamada Y; Harada M; Hashimoto K; Guo R; Nakajima T; Kashihara T; Yamada M; Aoyama T; Kamijo Y
Glycoconj J; 2019 Feb; 36(1):1-11. PubMed ID: 30536036
[TBL] [Abstract][Full Text] [Related]
9. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
[TBL] [Abstract][Full Text] [Related]
10. Association between serum magnesium and risk factors of cardiovascular disease in hemodialysis patients.
Khatami MR; Mirchi E; Khazaeipour Z; Abdollahi A; Jahanmardi A
Iran J Kidney Dis; 2013 Jan; 7(1):47-52. PubMed ID: 23314142
[TBL] [Abstract][Full Text] [Related]
11. Quantification of sulfatides and lysosulfatides in tissues and body fluids by liquid chromatography-tandem mass spectrometry.
Mirzaian M; Kramer G; Poorthuis BJ
J Lipid Res; 2015 Apr; 56(4):936-43. PubMed ID: 25632048
[TBL] [Abstract][Full Text] [Related]
12. Cardiac troponins have no prognostic value for acute and chronic cardiac events in asymptomatic patients with end-stage renal failure.
Lang K; Schindler S; Forberger C; Stein G; Figulla HR
Clin Nephrol; 2001 Jul; 56(1):44-51. PubMed ID: 11499658
[TBL] [Abstract][Full Text] [Related]
13. Apelin: a potential link between inflammation and cardiovascular disease in end stage renal disease patients.
El-Shehaby AM; El-Khatib MM; Battah AA; Roshdy AR
Scand J Clin Lab Invest; 2010 Oct; 70(6):421-7. PubMed ID: 20645679
[TBL] [Abstract][Full Text] [Related]
14. Imaging of complex sulfatides SM3 and SB1a in mouse kidney using MALDI-TOF/TOF mass spectrometry.
Marsching C; Eckhardt M; Gröne HJ; Sandhoff R; Hopf C
Anal Bioanal Chem; 2011 Jul; 401(1):53-64. PubMed ID: 21359825
[TBL] [Abstract][Full Text] [Related]
15. Levels of plasma sulfatides C18 : 0 and C24 : 1 correlate with disease status in relapsing-remitting multiple sclerosis.
Moyano AL; Pituch K; Li G; van Breemen R; Mansson JE; Givogri MI
J Neurochem; 2013 Dec; 127(5):600-4. PubMed ID: 23777394
[TBL] [Abstract][Full Text] [Related]
16. N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis.
Madsen LH; Ladefoged S; Corell P; Schou M; Hildebrandt PR; Atar D
Kidney Int; 2007 Mar; 71(6):548-54. PubMed ID: 17299526
[TBL] [Abstract][Full Text] [Related]
17. Effects of lipid-lowering therapy on reduction of cardiovascular events in patients with end-stage renal disease requiring hemodialysis.
Marrs JC; Saseen JJ
Pharmacotherapy; 2010 Aug; 30(8):823-9. PubMed ID: 20653359
[TBL] [Abstract][Full Text] [Related]
18. The influence of serum 25-hydroxy vitamin D levels on Helicobacter Pylori Infections in patients with end-stage renal failure on regular hemodialysis.
Nasri H; Baradaran A
Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):215-9. PubMed ID: 17496397
[TBL] [Abstract][Full Text] [Related]
19. Serum Gamma-Glutamyltransferase Levels Predict Clinical Outcomes in Hemodialysis Patients.
Park WY; Koh ES; Kim SH; Kim YO; Jin DC; Song HC; Choi EJ; Kim YL; Kim YS; Kang SW; Kim NH; Yang CW; Kim YK
PLoS One; 2015; 10(9):e0138159. PubMed ID: 26376075
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin and cardiovascular outcomes among hemodialysis patients.
Abdallah E; Waked E; Nabil M; El-Bendary O
Kidney Blood Press Res; 2012; 35(4):247-53. PubMed ID: 22286012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
